BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7170227)

  • 1. [Endogenous bile acids in the blood as a functional test in chronic liver diseases. I. Comparison with the antipyrine elimination test].
    Habior A
    Pol Arch Med Wewn; 1982; 68(3):125-32. PubMed ID: 7170227
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endogenous bile acids in the blood as a functional test in chronic liver diseases. II. Comparison with traditional liver function tests].
    Habior A
    Pol Arch Med Wewn; 1982; 68(3):133-9. PubMed ID: 7170228
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of antipyrine clearance in chronic liver diseases].
    Wang JL; Zhang F; Yuan SY
    Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):295-7, 315-6. PubMed ID: 2553353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of the determination of bile acids in the blood and antipyrine elimination in the diagnosis of minimal liver damage].
    Habior A
    Przegl Lek; 1983; 40(5):431-4. PubMed ID: 6622742
    [No Abstract]   [Full Text] [Related]  

  • 5. The association between rifamycin-SV (R-SV) related hyperbilirubinaemia and antipyrine clearance as a new test of liver function in cirrhosis.
    Persico M; Romano M; Villano N; Montella F; Gentile S
    Eur J Clin Invest; 1994 Mar; 24(3):201-4. PubMed ID: 8033955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bile salts, copper, ceruloplasmin in meal test].
    Fazzin G; Barelli A; D'Aquino M; Della Sala S; Michieletto L; Saonato F
    Quad Sclavo Diagn; 1987 Dec; 23(4):355-61. PubMed ID: 3508297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subchronic treatment with natural human interferons on antipyrine clearance and liver function in patients with chronic hepatitis.
    Echizen H; Ohta Y; Shirataki H; Tsukamoto K; Umeda N; Oda T; Ishizaki T
    J Clin Pharmacol; 1990 Jun; 30(6):562-7. PubMed ID: 2113064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct assessment of the mechanism of raised serum bile acid in chronic liver disease.
    de Caestecker JS; Jazrawi RP; Northfield TC
    Eur J Gastroenterol Hepatol; 1995 Oct; 7(10):1011. PubMed ID: 8590133
    [No Abstract]   [Full Text] [Related]  

  • 9. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Natural history of chronic hepatitis B].
    Schalm SW
    Acta Gastroenterol Belg; 1983; 46(3-4):115-24. PubMed ID: 6659847
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous tryptophan tolerance test for liver function.
    Zhu SS; Hu F; Li DG; Jin GQ; Jiang SJ; Lu HM; Li R
    Chin Med J (Engl); 1990 Feb; 103(2):146-51. PubMed ID: 2167818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic significance of fasting serum bile acid in liver disease.
    Hirayama C; Irisa T; Arimura K; Nakamura M
    Acta Hepatogastroenterol (Stuttg); 1976; 23(6):385-91. PubMed ID: 188286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bile acid metabolism in patients with chronic hepatitis and liver cirrhosis].
    Klemashev IS; Dorofeev AA
    Sov Med; 1984; (6):44-6. PubMed ID: 6463746
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnostic value of serum bile acids in chronic diseases of the liver].
    Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G
    Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731
    [No Abstract]   [Full Text] [Related]  

  • 15. Endogenous bile acid tolerance test and its clinical significance--series of total bile acid levels in plasma before and after contraction of the gallbladder in patients with chronic liver diseases.
    Iwamura K
    Tokai J Exp Clin Med; 1980 Jan; 5(1):113-29. PubMed ID: 7385259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bile acid concentration in serum after a test meal in hepatobiliary diseases. A comparison with quantitative liver function tests].
    Grandjean EM; Paumgartner G; Preisig R
    Schweiz Med Wochenschr; 1979 Sep; 109(35):1280-4. PubMed ID: 524095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct assessment of the mechanism for a raised serum bile acid level in chronic liver disease.
    de Caestecker JS; Jazrawi RP; Nisbett JA; Joseph AE; Maxwell JD; Northfield TC
    Eur J Gastroenterol Hepatol; 1995 Oct; 7(10):955-61. PubMed ID: 8590141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients.
    Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S
    Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conjugated serum bile acids in chronic liver diseases and cholestasis].
    Frosch B; Wagener H
    Acta Hepatosplenol; 1971; 18(4):273-86. PubMed ID: 5110093
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitivity of serum bile acid assay for detection of liver damage in viral hepatitis type B. Prospective study in five patients.
    Hofmann AF; Korman MG; Krugman S
    Am J Dig Dis; 1974 Oct; 19(10):908-10. PubMed ID: 4421567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.